Measured Risk Portfolios Inc. decreased its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 6.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,616 shares of the financial services provider’s stock after selling 500 shares during the quarter. CME Group makes up 2.0% of Measured Risk Portfolios Inc.’s portfolio, making the stock its 19th largest position. Measured Risk Portfolios Inc.’s holdings in CME Group were worth $2,099,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Wayfinding Financial LLC bought a new stake in CME Group during the 1st quarter valued at about $25,000. Webster Bank N. A. increased its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the period. Cornerstone Planning Group LLC increased its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Highline Wealth Partners LLC increased its position in CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the period. Finally, Golden State Wealth Management LLC increased its position in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 98 shares during the period. Institutional investors own 87.75% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have commented on CME shares. Barclays set a $298.00 target price on shares of CME Group and gave the company an “equal weight” rating in a research report on Thursday, July 24th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research report on Saturday, September 27th. UBS Group cut their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research report on Monday, September 8th. Morgan Stanley raised their target price on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Six analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $274.15.
CME Group Stock Down 0.3%
Shares of CME Group stock opened at $264.67 on Friday. The firm’s 50 day moving average price is $269.98 and its 200-day moving average price is $271.13. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The company has a market cap of $95.38 billion, a P/E ratio of 25.62, a PEG ratio of 5.57 and a beta of 0.41.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the firm earned $2.56 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 48.40%.
Insider Activity at CME Group
In related news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Company insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Do ETFs Pay Dividends? What You Need to Know
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- What Are Treasury Bonds?
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.